Management of ovarian germ cell tumors

Journal of Clinical Oncology

Volumn 25, Issue 20, 2007, Pages 2938-2943

  Gershenson, David M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

CANCER CLASSIFICATION; CANCER SURGERY; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG RESPONSE; DYSGERMINOMA; GERM CELL TUMOR; HUMAN; MALIGNANT OVARIAN GERM CELL TUMOR; METASTASIS; MONOTHERAPY; NEUROECTODERM TUMOR; OVARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TESTIS CANCER; TREATMENT OUTCOME; FEMALE; METHODOLOGY; NEOPLASM; ONCOLOGY; PROGNOSIS;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME;

EID: 34447526802     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.8738     Document Type: Review

References (56)

1. Norris HJ, Zirkin HJ, Benson WL: Immature (malignant) teratoma of the ovary: A clinical and pathologic study of 58 cases. Cancer 37:2359-2372, 1976
2. Kurman RJ, Norris HJ: Malignant mixed germ cell tumors of the ovary: A clinical and pathologic analysis of 30 cases. Obstet Gynecol 48:579-589, 1976
3. Kurman RJ, Norris HJ: Embryonal carcinoma of the ovary: A clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer 38:2420-2433, 1976
4. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 38:2404-2419, 1976
5. Kurman RJ, Norris HJ: Malignant germ cell tumors of the ovary. Hum Pathol 8:551-564, 1977
6. Jimerson GK, Woodruff JD: Ovarian extraembryonal teratoma: I. Endodermal sinus tumor. Am J Obstet Gynecol 127:73-79, 1977
7. Jimerson GK, Woodruff JD: Ovarian extraembryonal teratoma: II. Endodermal sinus tumor mixed with other germ cell tumors. Am J Obstet Gynecol 127:302-305, 1977
8. Gershenson DM, Del Junco G, Herson J, et al: Endodermal sinus tumor of the ovary: The M.D. Anderson experience. Obstet Gynecol 61:194-202, 1983
9. Gershenson DM, Del Junco G, Copeland LJ, et al: Mixed germ cell tumors of the ovary. Obstet Gynecol 64:200-206, 1984
10. Gershenson DM, del Junco G, Silva EG, et al: Immature teratoma of the ovary. Obstet Gynecol 68:624-629, 1986
11. Serov SF, Scully RE, Sobin LH: Histological typing of ovarian tumours: International histological classification of tumours, No. 9, Geneva, World Health Organization, 1973
12. Scully RE, Sobin LH: Histological Typing of Ovarian Tumours: World Health Organization International Histological Classification of Tumours (ed 2). Berlin, Germany, Springer, 1999
13. Tavassoli FA, Deville P: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France, International Agency for Research on Cancer, 2003
14. Roth LM, Talerman A: Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol 25:305-320, 2006
15. Lai CH, Chang TC, Hsueh S, et al: Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol 96:784-791, 2005
16. Murugaesu N, Schmid P, Dancey G, et al: Malignant ovarian germ cell tumors: Identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 24:4862-4866, 2006
17. Beiner ME, Gotlieb WH, Korach Y, et al: Cystectomy for immature teratoma of the ovary. Gynecol Oncol 93:381-384, 2004
18. Billmire D, Vinocur C, Rescorla F, et al: Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: An intergroup study. J Pediatr Surg 39:424-429, 2004; discussion 429
19. Slayton RE, Park RC, Silverberg SG, et al: Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: A Gynecologic Oncology Group Study (a final report). Cancer 56:243-248, 1985
20. Williams SD, Blessing JA, Moore DH, et al: Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors: A trial of the Gynecologic Oncology Group. Ann Intern Med 111: 22-27, 1989
21. Gershenson DM, Copeland LJ, del Junco G, et al: Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 67:789-793, 1986
22. Williams SD, Blessing JA, DiSaia PJ, et al: Second-look laparotomy in ovarian germ cell tumors: The Gynecologic Oncology Group experience. Gynecol Oncol 52:287-291, 1994
23. Messing MJ, Gershenson DM, Morris M, et al: Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer 2:295-300, 1992
24. Munkarah A, Gershenson DM, Levenback C, et al: Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 55:217-223, 1994
25. Gershenson DM, Copeland LJ, Kavanagh JJ, et al: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide. Cancer 56: 2756-2761, 1985
26. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
27. Gershenson DM, Kavanagh JJ, Copeland LJ, et al: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin. Cancer 57:1731-1737, 1986
28. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
29. Gershenson DM, Morris M, Cangir A, et al: Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8:715-720, 1990
30. Williams S, Blessing JA, Liao SY, et al: Adjuvant therapy of ovarian germ cell tumors with cis-platin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 12:701-706, 1994
31. Gershenson DM, Wharton JT, Kline RC, et al: Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity. Cancer 58:2594-2599, 1986
32. Williams SD, Blessing JA, Hatch KD, et al: Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 9:1950-1955, 1991
33. Brewer M, Gershenson DM, Herzog CE, et al: Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17:2670-2675, 1999
34. Williams SD, Kauderer J, Burnett AF, et al: Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: A trial of the Gynecologic Oncology Group. Gynecol Oncol 95:496-499, 2004
35. Bonazzi C, Peccatori F, Colombo N, et al: Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet Gynecol 84:598-604, 1994
36. Dark GG, Bower M, Newlands ES, et al: Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 15:620-624, 1997
37. Mitchell PL, Al-Nasiri N, A'Hern R, et al: Treatment of nondysgerminomatous ovarian germ cell tumors: An analysis of 69 cases. Cancer 85:2232-2244, 1999
38. Cushing B, Giller R, Ablin A, et al: Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: A report of the Pediatric Oncology Group and the Children's Cancer Group. Am J Obstet Gynecol 181:353-358, 1999
39. Marina NM, Cushing B, Giller R, et al: Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/ Children's Cancer Group Intergroup Study. J Clin Oncol 17:2137-2143, 1999
40. Gobel U, Schneider DT, Calaminus G, et al: Germ-cell tumors in childhood and adolescence: GPOH MAKEI and the MAHO study groups. Ann Oncol 11:263-271, 2000
41. Baranzelli M, Bouffet E, Quintana E, et al: Non-seminomatous ovarian germ cell tumours in children. Eur J Cancer 36:376-383, 2000
42. Gershenson DM: Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6:270-275, 1988
43. Low JJH, Perrin LC, Crandon J, et al: Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors: A review of 74 cases. Cancer 89:391-398, 2000
44. Zanetta G, Bonazzi C, Cantu MG, et al: Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19:1015-1020, 2001
45. Tangir J, Zelterman D, Ma W, et al: Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 101:251-257, 2003
46. Sklar CA, Mertens AC, Mitby P, et al: Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 98:890-896, 2006
47. Pedersen-Bjergaard J, Daugaard G, Hansen SW, et al: Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 338:359-363, 1991
48. Nichols CR, Breeden ES, Loehrer PJ, et al: Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols. J Natl Cancer Inst 85:36-40, 1993
49. Loehrer PJ Sr, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988
50. Loehrer PJ Sr, Gonin R, Nichols CR, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998
51. McCaffrey JA, Mazumdar M, Bajorin DF, et al: Ifosfamide and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors; response and survival. J Clin Oncol 15:2559-2563, 1997
52. Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
53. Broun ER, Nichols CR, Gize G, et al: Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 79:605-610, 1997
54. Bhatia S, Abonour R, Porcu P, et al: High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18:3346-3351, 2000
55. Motzer RJ, Mazumdar M, Sheinfeld J, et al: Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18:1173-1180, 2000
56. Motzer RJ, Nichols CJ, Margolin KA, et al: Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25:247-256, 2007